Press "Enter" to skip to content

New patent for Merck Sharp drug NOXAFIL

0
Copyright © DrugPatentWatch. Originally published at New patent for Merck Sharp drug NOXAFIL

Annual Drug Patent Expirations for NOXAFIL
Annual Drug Patent Expirations for NOXAFIL

Noxafil is a drug marketed by Merck Sharp Dohme, Schering, and Msd Merck Co and, and is included in four NDAs. It is available from three suppliers. There are seven patents protecting this drug and three Paragraph IV challenges.

NOXAFIL drug price trends.

Drug patent litigation for NOXAFIL.

This drug has eigthy-nine patent family members in twenty-one countries.

The generic ingredient in NOXAFIL is posaconazole. Three suppliers are listed for this compound. Additional details are available on the posaconazole profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Merck Sharp drug NOXAFIL
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions